These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function. Tousoulis D; Marinou K; Stefanadis C J Appl Physiol (1985); 2008 Jul; 105(1):379; author reply 389. PubMed ID: 18292302 [No Abstract] [Full Text] [Related]
5. [Prevention with vasoactive drugs]. Motz W; Vogt M; Scheler S; Schwartzkopff BE; Kelm M; Strauer BE Z Kardiol; 1992; 81 Suppl 4():199-204. PubMed ID: 1290299 [TBL] [Abstract][Full Text] [Related]
6. [Myocardial ischemia in disorders of coronary microcirculation]. Motz W; Vogt M; Scheler S; Schwartzkopff B; Strauer BE Verh Dtsch Ges Inn Med; 1991; 97():529-32. PubMed ID: 1808940 [No Abstract] [Full Text] [Related]
7. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease. Strauer BE; Schwartzkopff B Blood Press Suppl; 1997; 2():6-12. PubMed ID: 9495619 [TBL] [Abstract][Full Text] [Related]
8. [Hypertension and the coronary circulation]. Fedele F; Romano S Ital Heart J; 2000 Jun; 1 Suppl 2():13-6. PubMed ID: 10905123 [TBL] [Abstract][Full Text] [Related]
9. Myocardial ischaemia in the hypertensive patient--the role of coronary microcirculation abnormalities. Kaski JC Eur Heart J; 1993 Nov; 14 Suppl J():32-7. PubMed ID: 8281960 [TBL] [Abstract][Full Text] [Related]
11. Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application. L'Abbate A; Sambuceti G; Neglia D J Nucl Cardiol; 2002; 9(3):328-37. PubMed ID: 12032481 [No Abstract] [Full Text] [Related]
12. [The importance of microcirculation and tissue perfusion in hypertension]. Lévy BI Curr Med Res Opin; 2005; 21 Suppl 5():S1-6. PubMed ID: 16197644 [TBL] [Abstract][Full Text] [Related]
13. Coronary microvascular dysfunction and ventricular noncompaction: the chicken or the egg, or both the consequence of a certain undetermined cause? Song ZZ Cardiol Young; 2008 Oct; 18(5):549-50. PubMed ID: 18706135 [No Abstract] [Full Text] [Related]
14. Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy? Yalta K; Sivri N; Yalta T Int J Cardiol; 2011 Mar; 147(2):284. PubMed ID: 21145602 [No Abstract] [Full Text] [Related]
16. [Endothelial function and coronary microcirculation in arterial hypertension]. Salvetti A Cardiologia; 1996 Apr; 41(4):319-25. PubMed ID: 8674100 [No Abstract] [Full Text] [Related]
17. Coronary flow reserve in dilated cardiomyopathy: an important pathophysiological tool to be considered among, but not instead of, other well-established prognostic factors. de Gregorio C Eur Heart J; 2006 Nov; 27(21):2609; author reply 2609-10. PubMed ID: 17030520 [No Abstract] [Full Text] [Related]
18. [Postischemic changes in the permeability of coronary microcirculation and ventricular remodeling]. Barsotti A; Di Napoli P; Soccio M; Di Muzio M; Spoletini L; Dini FL; Gallina S; D'Annunzio E; Modesti A Cardiologia; 1995 Dec; 40(12 Suppl 1):57-65. PubMed ID: 8998776 [No Abstract] [Full Text] [Related]
19. Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion. Mourad JJ; Laville M J Hypertens Suppl; 2006 Aug; 24(5):S10-6. PubMed ID: 16936530 [TBL] [Abstract][Full Text] [Related]
20. The concept of coronary flow reserve. Strauer BE J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S67-80. PubMed ID: 1381797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]